RxSight
RXST
74 hedge funds and large institutions have $264M invested in RxSight in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 5 closing their positions.
885% more call options, than puts
Call options by funds: $1.15M | Put options by funds: $117K
340% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 5
267% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 9
118% more capital invested
Capital invested by funds: $121M → $264M (+$143M)
30% more funds holding
Funds holding: 57 → 74 (+17)
12.32% more ownership
Funds ownership: 34.6% → 46.92% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$37.4M |
| 2 |
JP Morgan Chase
New York
|
+$7.82M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$6.64M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.78M |
| 5 |
Millennium Management
New York
|
+$4.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$3.84M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$1.16M |
| 3 |
ACM
Altium Capital Management
New York
|
-$641K |
| 4 |
MCCA
Mill Creek Capital Advisors
Conshohocken,
Pennsylvania
|
-$252K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$203K |
RXST Hedge Fund Activity: Q1 2023 in Review
74 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q1 2023, worth a combined $264M — up 118% from $121M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new RXST positions and 5 closed out — a net gain of 17 holders — while 33 added to existing stakes and 9 trimmed.
The largest buyer was Artisan Partners, opening a new position worth an estimated $37.4M. The largest seller was Cresset Asset Management, exiting entirely with an estimated $3.84M sold.
- 74 institutional investors held RxSight (RXST) as of Q1 2023, up from 57 in Q4 2022.
- Funds reported $264M of RxSight stock for Q1 2023, up 118% quarter-over-quarter.
- 22 funds opened new RxSight positions in Q1 2023 and 5 closed out, a net change of +17 holders.
- The largest RxSight buyer in Q1 2023 was Artisan Partners, an estimated $37.4M added.
- The largest RxSight seller in Q1 2023 was Cresset Asset Management, an estimated $3.84M sold.
Based on aggregated 13F filings for Q1 2023.